Edition:
India

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

1.12USD
2:29am IST
Change (% chg)

$0.02 (+1.82%)
Prev Close
$1.10
Open
$1.12
Day's High
$1.18
Day's Low
$1.09
Volume
33,557
Avg. Vol
60,366
52-wk High
$12.59
52-wk Low
$1.04

Latest Key Developments (Source: Significant Developments)

Iroquois Capital Management Reports 9.99 Pct Passive Stake In Tenax Therapeutics
Saturday, 15 Dec 2018 

Dec 14 (Reuters) - Tenax Therapeutics Inc ::IROQUOIS CAPITAL MANAGEMENT LLC REPORTS A 9.99 PERCENT PASSIVE STAKE IN TENAX THERAPEUTICS AS OF DEC 7, 2018 - SEC FILING.  Full Article

Tenax Therapeutics Files For Mixed Shelf Of Up To $75 Mln
Wednesday, 16 May 2018 

May 15 (Reuters) - Tenax Therapeutics Inc ::TENAX THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $75 MILLION – SEC FILING.  Full Article

Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Tenax Therapeutics Inc ::TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES.TENAX THERAPEUTICS - PHASE 2 TRIAL TO INVESTIGATE LEVOSIMENDAN IN PULMONARY HYPERTENSION-WHO GROUP 2 PATIENTS WITH PRESERVED EJECTION FRACTION.TENAX THERAPEUTICS INC - PLANS TO INITIATE PHASE 2 TRIAL IN PH-HFPEF PATIENTS IN EARLY PART OF Q3 OF 2018.TENAX THERAPEUTICS INC - ‍PRE-IND MEETING IS SCHEDULED WITH FDA TO DISCUSS DEVELOPMENT OF LEVOSIMENDAN IN PH-HFPEF IN COMING MONTHS​.  Full Article